Genetic rickets improves more with burosumab than standard care, study finds
Burosumab, a new injectable medicine to treat X-linked hypophosphatemia (XLH), an inherited form of rickets, demonstrates superior improvements in rickets and other outcomes compared with conventional therapy in an international, ...
Mar 24, 2019
0
1